ANAVEX LIFE SCIENCES CORP.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-9.6M | $-9.6M | — | $4.4M |
| Jun 2022 | $-7.1M | $-7.1M | — | $4.0M |
| Sep 2022 | $-4.0M | $-4.0M | — | $6.0M |
| Dec 2022 | $-5.8M | $-5.8M | — | $5.3M |
| Mar 2023 | $-8.5M | $-8.5M | — | $4.0M |
| Jun 2023 | $-7.7M | $-7.7M | — | $3.9M |
| Sep 2023 | $-5.8M | $-5.8M | — | $3.2M |
| Dec 2023 | $-7.3M | $-7.3M | — | $2.3M |
| Mar 2024 | $-11.7M | $-11.7M | — | $2.7M |
| Jun 2024 | $-5.2M | $-5.2M | — | $2.5M |
| Sep 2024 | $-6.7M | $-6.7M | — | $2.0M |
| Dec 2024 | $-12.1M | $-12.1M | — | $2.1M |
| Mar 2025 | $-5.9M | $-5.9M | — | $1.4M |
| Jun 2025 | $-12.5M | $-12.5M | — | $4.3M |
| Sep 2025 | $-8.6M | $-8.6M | — | $3.7M |
| Dec 2025 | $-7.2M | $-7.2M | — | $1.1M |
| Mar 2026 | $-4.4M | $-4.4M | — | $314.0K |
| Jun 2026 | $-9.1M | $-9.1M | — | $-17.1M |